Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Ann Allergy Asthma Immunol. 2011 Aug;107(2):154-62. doi: 10.1016/j.anai.2011.05.001. Epub 2011 Jun 12.
Asthma is a significant disease among children, and its prevalence has increased notably during the last 2 decades. A traditional Korean medicine, So-Cheong-Ryong-Tang (SCRT), has been used for the treatment of asthma in Asia for centuries, but its mechanism for reducing bronchopulmonary inflammation in asthma has yet to be elucidated.
To investigate whether the herbal extract SCRT inhibits inflammation in a mouse model of cockroach allergen-induced asthma.
A house dust extract containing endotoxin and cockroach allergens was used for immunization and 2 additional pulmonary challenges in BALB/c mice. Mice were treated with SCRT or vehicle 1 hour before each pulmonary challenge. Respiratory parameters were evaluated by whole-body plethysmography and forced oscillation methods 24 hours after the last challenge. Bronchoalveolar lavage (BAL) fluid was collected, and histologic sections of lung were prepared either 4 or 24 hours after the last house dust extract challenge.
SCRT treatment significantly reduced the hyperreactivity of the airways as measured by whole-body plethysmography and direct measurement of airway resistance. Inflammation was significantly inhibited by SCRT treatment as demonstrated by reduced plasma IgE levels and improved pulmonary histologic characteristics. SCRT significantly reduced the number of neutrophils in the BAL fluid and also significantly reduced the BAL levels of CXC chemokines, providing a potential mechanism for the reduced inflammation. In a similar fashion, SCRT reduced eosinophil recruitment and BAL levels of eotaxin and RANTES.
These data indicate that SCRT treatment alleviates asthma-like pulmonary inflammation via suppression of specific chemokines.
哮喘是儿童的一种重大疾病,在过去 20 年中,其发病率显著增加。一种传统的韩国药物,四合红竜汤(SCRT),已在亚洲用于治疗哮喘数百年,但它减轻哮喘支气管肺炎症的机制尚未阐明。
研究草药提取物 SCRT 是否抑制蟑螂过敏原诱导的哮喘小鼠模型中的炎症。
使用含有内毒素和蟑螂过敏原的房屋灰尘提取物对 BALB/c 小鼠进行免疫接种和另外 2 次肺部挑战。在每次肺部挑战前 1 小时,用 SCRT 或载体处理小鼠。在最后一次挑战后 24 小时,通过全身 plethysmography 和强迫振荡方法评估呼吸参数。收集支气管肺泡灌洗液(BAL),并在最后一次房屋灰尘提取物挑战后 4 或 24 小时制备肺组织学切片。
SCRT 治疗显著降低了全身 plethysmography 和气道阻力直接测量所测气道高反应性。SCRT 治疗显著抑制了炎症,表现为血浆 IgE 水平降低和肺部组织学特征改善。SCRT 显著减少 BAL 液中的中性粒细胞数量,并显著降低 BAL 水平的趋化因子 CXC,为减轻炎症提供了潜在机制。同样,SCRT 减少了嗜酸性粒细胞募集和 BAL 水平的嗜酸性粒细胞趋化因子和 RANTES。
这些数据表明,SCRT 治疗通过抑制特定趋化因子缓解哮喘样肺部炎症。